Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
- 1 April 2007
- Vol. 56 (4), 453-455
- https://doi.org/10.1136/gut.2005.088732
Abstract
The main goal of treatment for Crohn's disease and ulcerative colitis has always been the induction and maintenance of symptomatic improvement or at best remission. It has been shown by many studies that the long-term outcome of these diseases is not influenced by standard treatments and that the need for surgery is not decreasing in this population over the years. There is recent evidence that with immunosuppression and treatment with infliximab long-term healing of the bowel can be achieved and that this affects the outcome of both Crohn's disease and ulcerative colitis. We propose that future studies should focus on healing and disease course as primary outcome measures.Keywords
This publication has 15 references indexed in Scilit:
- Natalizumab Induction and Maintenance Therapy for Crohn's DiseaseNew England Journal of Medicine, 2005
- A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on AzathioprineGastroenterology, 2005
- Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CDGastrointestinal Endoscopy, 2004
- Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s diseaseGastroenterology, 2004
- Long-Term Evolution of Disease Behavior of Crohn's DiseaseInflammatory Bowel Diseases, 2002
- Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprineGastrointestinal Endoscopy, 1999
- Clinical, biological, and endoscopic picture of attacks of Crohn's diseaseGastroenterology, 1990
- Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation.Gut, 1990
- Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).Gut, 1989
- Methotrexate Induces Clinical and Histologic Remission in Patients with Refractory Inflammatory Bowel DiseaseAnnals of Internal Medicine, 1989